Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...

Context Explanation

Brazil: Brazilian researchers have found in a new study, published in The New England Journal of Medicine, that dengue infection is associated with an increased risk of Guillain–Barré syndrome (GBS), ... Guillain–Barré syndrome (GBS) is a rare autoimmune disorder, affecting as many as 6,000 people each year in the United States, but its risk increases with age. In the U.S., it’s most commonly seen in ... The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy).

Insight Material

The ... MedPage Today on MSN: Risk of Guillain–Barre Syndrome Rises After Dengue Infection GBS occurrence was highest in the first 2 weeks after dengue symptom onset ... A new study from Israel indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus. Photo by Ian ... Yahoo: What is Guillain-Barre Syndrome?

Final Conclusion

Everything we know about the rare autoimmune disorder